Prognosis in iatrogenic gas embolism | Canada Hyperbarics Skip to main content
Review Minerva Med 1995

Prognosis in iatrogenic gas embolism

Boussuges A, Blanc P, Molenat F, Bergmann E, Sainty J — Minerva Med, 1995

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at records of 113 patients treated with hyperbaric oxygen therapy for iatrogenic air embolism to understand factors affecting their recovery.

What They Found

Of the 113 patients, 71% presented with neurological disorders, 43% with respiratory issues, and 33% with hemodynamic problems. Overall, 69% recovered, 26% experienced lasting effects, and 5% died. Patients with venous emboli showed better improvement than those with arterial emboli. Hyperbaric oxygen therapy protocols varied, with neurological cases receiving initial compression to 6 atmospheres absolute (ATA) for 10-15 minutes followed by 100% oxygen at 2 ATA for one hour, while non-neurological cases received 100% oxygen at 2 ATA for one hour.

Canadian Relevance

This study covers iatrogenic gas embolism, which can include arterial gas embolism, a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

A limitation of this study is its retrospective design, which relies on existing patient records and may not capture all relevant details.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 8684668
Year Published 1995
Journal Minerva Med
MeSH Terms Adolescent; Adult; Aged; Aged, 80 and over; Catheterization, Central Venous; Embolism, Air; Female; Humans; Hyperbaric Oxygenation; Iatrogenic Disease; Male; Middle Aged; Postoperative Complications; Prognosis; Renal Dialysis

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology